Industry Voices

While autologous live cell therapies are not new, Royal Biologics is creating a unique value proposition through its growing ALC portfolio.

Technology updates, the competitive landscape and surgeon and patient interest are pushing orthopedic companies to speed robotic iterations and innovations.

The differences between the hospital and ASC setting are vast and present a learning curve for those managing, operating in and selling to outpatient centers. However, the growth opportunity connected to ASCs is significant for those companies that examine the big picture and build foundational relationships.

OEM and contract manufacturer executives share that businesses can prepare for disruptions by fostering resilient business plans, leadership and team members.

Often, when a business reaches a certain level of maturity leadership begins to think about expansion beyond their original products or their home market. But what does that growth look like, and how might you accomplish it?

Mr. Lin has led the U.S. operations for United Orthopedic for more than a decade. He has learned that trust and people are the most critical factors in a successful business.

ZygoFix zLOCK technology facilitates a percutaneous approach to lumbar fusion. By fusing the facet joint with a small but rigid titanium implant, surgeons can stabilize the back and bring on pain relief in a less invasive way.